Go to the list of all blogs
Allana's Avatar
published in Blogs
Oct 25, 2026
Amplify Alternative Harvest ETF (MJ): Weighing Cannabis Policy Shifts and Portfolio Dynamics

Amplify Alternative Harvest ETF (MJ): Weighing Cannabis Policy Shifts and Portfolio Dynamics

Key Takeaways

  • Regulatory momentum is the dominant macro driver. The trajectory of US cannabis rescheduling and federal reform remains the single largest swing factor for the fund's future outlook.
  • Concentrated, dual-market portfolio exposure. The fund blends Canadian licensed producers (LPs) with US multi-state operators (MSOs), making it sensitive to both provincial market dynamics and US federal policy.
  • High single-name concentration raises idiosyncratic risk. A top holding in another cannabis ETF plus a handful of individual operators concentrates the fund's sector outlook in relatively few names.
  • Fund flow trends reflect risk appetite. Cannabis ETFs tend to attract inflows on legalization headlines and shed assets when macro risk sentiment weakens, amplifying volatility.
  • Key catalysts ahead include federal scheduling decisions, tax reform, and global legalization. German market expansion and potential US banking and tax relief are among the most consequential developments to monitor.

Portfolio Exposure and ETF Strategy Overview

The Amplify Alternative Harvest ETF seeks to track the Prime Alternative Harvest Index, a rules-based benchmark of global companies engaged in the legal cultivation, production, marketing, and distribution of cannabis and related products. The index identifies firms deriving a meaningful share of revenue from cannabis and ancillary activities, and applies a proprietary weighting methodology that caps the largest primary beneficiaries while equal-weighting secondary beneficiaries.

The fund's portfolio exposure is heavily concentrated in healthcare and consumer-defensive businesses, with the majority of underlying revenue tied to regulated cannabis operations. Geographic allocation leans toward Canada and the United States, reflecting the most mature legal markets. Top positions typically include major Canadian licensed producers such as TLRY, CRON, CGC, SNDL, and ACB, alongside US-facing names and a sizable allocation to the Amplify Seymour Cannabis ETF (CNBS).

Structurally, the fund is non-diversified and carries a net expense ratio of approximately 0.75%. Its future performance potential is tightly linked to the pace of legalization, pricing discipline within oversupplied Canadian markets, and the ability of US operators to expand profitably as federal restrictions evolve. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Major Catalysts Ahead

  • US federal rescheduling and reform. Movement of cannabis from Schedule I to Schedule III under the Controlled Substances Act would ease a punitive federal tax burden on US operators and could unlock broader institutional participation, a pivotal catalyst for the MSO-heavy segment of the portfolio.
  • Banking and tax legislation. Passage of measures such as the SAFE Banking Act would improve access to traditional financial services and reduce cash-handling costs, directly improving the operating economics of many holdings.
  • Canadian excise tax and profitability. Efforts to reform Canada's excise tax regime and rationalize industry oversupply could support margin recovery among licensed producers, the fund's largest geographic exposure.
  • Global legalization momentum. Germany's regulated adult-use market and potential reform in other European jurisdictions represent structural growth avenues that could broaden revenue pools for globally positioned operators.
  • Earnings and balance-sheet execution. Given elevated debt levels and historical cash burn across the sector, quarterly results and liquidity management among top holdings will remain key sentiment drivers.

Sector, Index, and Macroeconomic Outlook

The cannabis sector sits at the intersection of consumer discretionary demand, healthcare-oriented products, and regulatory policy. Its macro outlook remains closely tied to interest rates and risk appetite: higher-for-longer rate environments raise financing costs for capital-intensive cultivators and weigh on the small-cap growth profile that dominates this asset class. Conversely, a more accommodative rate cycle could ease funding pressures and support a re-rating of growth-oriented holdings.

Inflation dynamics also matter, as input costs and pricing power vary across cultivation, processing, and retail segments. Broader equity market trends influence flows into thematic ETFs, while currency movements between the US dollar and Canadian dollar can affect the translated returns of the fund's substantial Canadian exposure. Ultimately, the index outlook hinges less on near-term macro data and more on the trajectory of legalization policy, industry consolidation, and the sector's shift toward sustainable free cash flow generation. From what I see, monitoring these elements through tools like Tickeron’s AI Trend Prediction Engine adds a useful layer to the analysis.

Long-Term Outlook and Structural Trends

Over the long term, the cannabis investment theme rests on three structural pillars: normalization of federal policy in the United States, maturation and consolidation of global markets, and the transition of leading operators toward consistent profitability. Demographic trends favoring broader social acceptance, combined with the medical-use growth opportunity in aging populations, provide a durable demand backdrop. Market structure changes, including mergers among cultivators and the rise of capital-efficient, asset-light models, could gradually improve industry economics.

The fund's long-term outlook is also shaped by index design. Quarterly rebalancing and concentration limits can shift exposure as individual names grow or contract, meaning the portfolio's composition may evolve with industry leadership. Interest rate cycles and global investment trends toward and away from thematic, higher-risk strategies will continue to influence capital availability and valuation multiples across the sector.

Exploring AI Tools for ETF Analysis

In my view, incorporating systematic signals can help clarify near-term direction amid policy uncertainty. I recently ran the holdings through Tickeron’s AI Trend Prediction Engine to get a data-driven sense of potential bullish, bearish, or sideways moves over the coming weeks. It surfaces developing trends and offers historical context that complements fundamental work on regulatory catalysts and balance-sheet trends. This approach keeps the focus on observable signals rather than speculation.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MJ

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


Momentum Indicator for MJ turns negative, indicating new downward trend

MJ saw its Momentum Indicator move below the 0 level on September 30, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 76 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for MJ turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 36 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

MJ moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MJ crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MJ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for MJ entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for MJ's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where MJ advanced for three days, in 189 of 212 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

MJ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Notable companies

The most notable companies in this group are Tilray Brands Inc. (NASDAQ:TLRY).

Industry description

The investment seeks investment results that generally correlate to the total return performance of the Prime Alternative Harvest Index. The fund will normally invest at least 80% of its net assets in the securities that comprise the index. The index seeks to provide exposure to global and U.S. companies that (i) engage in the cultivation, production, marketing or distribution of cannabis, including industrial hemp; and/or (ii) engage in the production, marketing, transportation or distribution of products containing cannabis, including industrial hemp, for medical or non-medical purposes. The fund is non-diversified.

Market Cap

The average market capitalization across the Amplify Alternative Harvest ETF (MJ) ETF is 15.4B. The market cap for tickers in the group ranges from 314.89M to 394.59M. TLRY holds the highest valuation in this group at 394.59M. The lowest valued company is VFF at 314.89M.

High and low price notable news

The average weekly price growth across all stocks in the Amplify Alternative Harvest ETF (MJ) ETF was -1%. For the same ETF, the average monthly price growth was -21%, and the average quarterly price growth was -20%. SNDL experienced the highest price growth at 3%, while TLRY experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Amplify Alternative Harvest ETF (MJ) ETF was 37%. For the same stocks of the ETF, the average monthly volume growth was 60% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 38
P/E Growth Rating: 62
Price Growth Rating: 60
SMR Rating: 74
Profit Risk Rating: 91
Seasonality Score: 6 (-100 ... +100)
View a ticker or compare two or three
MJ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category MiscellaneousSector

Category
Miscellaneous Sector
Address
Amplify ETF Trust3250 Lacey Road, Suite 130Downers Grove
Phone
(630) 464-7600
Web
N/A
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.